Moexipril HCL
Brand names,
Moexipril HCL
Analogs
Moexipril HCL
Brand Names Mixture
Moexipril HCL
Chemical_Formula
C66H83N17O13
Moexipril HCL
RX_link
http://www.rxlist.com/cgi/generic2/nafarelin.htm
Moexipril HCL
fda sheet
Moexipril HCL
msds (material safety sheet)
Moexipril HCL
Synthesis Reference
No information avaliable
Moexipril HCL
Molecular Weight
1321.6344 g/mol
Moexipril HCL
Melting Point
No information avaliable
Moexipril HCL
H2O Solubility
No information avaliable
Moexipril HCL
State
Solid
Moexipril HCL
LogP
No information avaliable
Moexipril HCL
Dosage Forms
Liquid; Metered-dose (aerosol)
Moexipril HCL
Indication
For treatment of gonadotropin-dependent precocious puberty in children of both sexes and for the treatment of endometriosis.
Moexipril HCL
Pharmacology
Nafarelin is a potent agonistic analog of gonadotropin-releasing hormone (GnRH). At the onset of administration, nafarelin stimulates the release of the pituitary gonadotropins, LH and FSH, resulting in a temporary increase of gonadal steroidogenesis. Repeated dosing abolishes the stimulatory effect on the pituitary gland. Twice daily administration leads to decreased secretion of gonadal steroids by about 4 weeks; consequently, tissues and functions that depend on gonadal steroids for their maintenance become quiescent. After nafarelin therapy is discontinued, pituitary and ovarian function normalize and estradiol serum concentrations increase to pretreatment levels. Recurrences of endometriosis are frequent after cessation of any hormonal therapy and after surgery that leaves the ovaries and/or uterus intact.
Moexipril HCL
Absorption
Rapidly absorbed into the systemic circulation after intranasal administration. Bioavailability from a 400 µg dose averaged 2.8% (range 1.2 to 5.6%). Not absorbed after oral administration.
Moexipril HCL
side effects and Toxicity
In experimental animals, a single subcutaneous administration of up to 60 times the recommended human dose (on a µg/kg basis, not adjusted for bioavailability) had no adverse effects. At present, there is no clinical evidence of adverse effects following overdosage of GnRH analogs.
Moexipril HCL
Patient Information
Moexipril HCL
Organisms Affected
Humans and other mammals